3Groenning BA,Nilsson JC,Sondergaard L,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.Eur J Heart Fail,2001,3(6):699～708.
4CHOBANIAN A V,BAKRIS G L, BLASK H R,et al. The seventh report of the joint committee on prevention,detection, evaluation, and treatment of high blood pressure :The JNC-7 report [ J ]. JAMA, 2003,289 ( 19 ) : 2560-2572.
6AUKRUSTP,VELANDT,LIENE,et al. Consensus.recommendation for the management of chronic heart faiture [J]. Am J cardiol, 1999,83 (2A) : 1A-38A.
7HOMING B,ARAKAWA N,DREXLER H. Ehect of ACE inhibition on endothelial dysfunction in patients with patients with chronic heart failure [J]. Eur heart J, 1989,19 (Suppl) : 48-53.
8PARRATT J R. Cardioprotection by angiotensin converting enzyme inhibitors the experimental evidence [J]. Cardiovase Res, 1994,28(2):183-189.
8KCDZIORA-KOMATOWSKA K,CZUCZEJKO J,PAWLUK H,etal.The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hy-pertension[J].Cell MOl Biol Lett,2004,9(4A):635-641.
9MODY N A,LOMAKIN O,DOGGETT T A,et al.Mechanics of transient platelet adhesion to von Willebrand factor under flow[J].Biophys J,2005,88(2):1432-1443.
